Overview
This report on diabetes injection pens market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of diabetes injection pens products such as insulin pen and pen needles as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global diabetes injection pens market with respect to the leading market segments based on major products segment, end users, and geographies.
Segmentation
Based on the product type, the diabetes injection pens market has been segmented into: insulin pen and pen needles. In term of diabetes injection pen usage products divided into reusable pens and disposable pens. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of diabetes incidences worldwide, technological advancement, and growing number of use of reusable pens in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2026, considering 2018 as the base year.
Global Diabetes Injection Pens Market: Drivers and Trends
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the diabetes injection pens market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global diabetes injection pens market.
Global Diabetes Injection Pens Market: Geographical Outlook
Geographically, diabetes injection pens market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2019 to 2026, considering 2018 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, pricing analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global diabetes injection pens market.
Key Players Mentioned in this Report are:
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global diabetes injection pens market. The report also profiles key players operating in the diabetes injection pens market which are Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon Ltd., Sanofi S.A., Becton, Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co. and Wockhardt Ltd. The global diabetes injection pens market is dominated by three global vendors that accounts for more than 74% share of the global market.
The global diabetes injection pens market is segmented as follows:
By Product Type
By Usage
By Distribution Channel
By Geography
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Diabetes Injection Pens Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Global Diabetes Injection Pens Market Size (US$ Mn) Forecast, 2016–2026
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Product Pricing Analysis
4.7. Global Diabetes Injection Pens Market Outlook
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increase in prevalence of diabetes
5.2.2. Growing number of insulin syringe needle stick injury cases
5.2.3. Improving patient compliance and acceptability of novel technologies
5.2.4. Innovations in digital insulin pen
5.2.5. Impetus from insulin market
5.2.6. Rise in incidence of pediatric diabetes and geriatric population diabetes
5.3. Restraints
5.3.1. Threat of alternative technologies for insulin delivery
5.3.2. Pricing pressures in U.S.
5.1. Opportunity Analysis
5.2. Technology Trend
5.2.1. Smart Insulin Pen Connected with Mobile App
5.2.2. Smart Insulin Pen Caps
5.2.3. Prominent Innovator in the Future of Connected Insulin Pens
5.2.4. Future of Connected Devices in Blood Glucose Monitoring
6. Global Diabetes Injection Pens Market Analysis, by Product Type
6.1. Introduction
6.2. Key Findings
6.3. Global Diabetes Injection Pens Market Value Share Analysis, by Product Type, 2016 and 2026
6.3.1. Insulin Pens
6.3.2. Pen Needles
6.4. Global Diabetes Injection Pens Market Attractiveness Analysis, by Product Type, 2016–2026
6.5. Key Trends
7. Global Diabetes Injection Pens Market Analysis, by Usage
7.1. Introduction
7.2. Key Findings
7.3. Global Diabetes Injection Pens Market Value Share Analysis, by Usage, 2016 and 2026
7.3.1. Reusable Pens
7.3.2. Disposable Pens
7.4. Global Diabetes Injection Pens Market Attractiveness Analysis, by Usage, 2016–2026
7.5. Key Trends
8. Global Diabetes Injection Pens Market Analysis, by Distribution Channel
8.1. Introduction
8.2. Key Findings
8.3. Global Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel, 2016-2026
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Online Sales
8.3.4. Diabetes Clinics/Centers
8.4. Global Diabetes Injection Pens Market Attractiveness Analysis, by Distribution Channel, 2016–2026
8.5. Key Trends
9. Global Diabetes Injection Pens Market Analysis, by Region
9.1. Global Market Scenario by Country
9.2. Global Diabetes Injection Pens Market Value Share Analysis, by Region, 2016 and 2026
10. North America Diabetes Injection Pens Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. North America Diabetes Injection Pens Market Value Share Analysis, by Country
10.4. North America Diabetes Injection Pens Market Value Share Analysis, by Product Type
10.5. North America Diabetes Injection Pens Market Value Share Analysis, by Usage
10.6. North America Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel
10.7. North America Diabetes Injection Pens Market Attractiveness Analysis
10.8. North America Diabetes Injection Pens Market Trends
11. Europe Diabetes Injection Pens Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Europe Diabetes Injection Pens Market Value Share Analysis, by Country
11.4. Europe Diabetes Injection Pens Market Value Share Analysis, by Product Type
11.5. Europe Diabetes Injection Pens Market Value Share Analysis, by Usage
11.6. Europe Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel
11.7. Europe Diabetes Injection Pens Market Attractiveness Analysis
11.8. Europe Diabetes Injection Pens Market Trends
12. Asia Diabetes Injection Pens Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Asia Diabetes Injection Pens Market Value Share Analysis, by Country
12.4. Asia Diabetes Injection Pens Market Value Share Analysis, by Product Type
12.5. Asia Diabetes Injection Pens Market Value Share Analysis, by Usage
12.6. Asia Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel
12.7. Asia Diabetes Injection Pens Market Attractiveness Analysis
12.8. Asia Diabetes Injection Pens Market Trends
13. Latin America Diabetes Injection Pens Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Latin America Diabetes Injection Pens Market Value Share Analysis, by Country
13.4. Latin America Diabetes Injection Pens Market Value Share Analysis, by Product Type
13.5. Latin America Diabetes Injection Pens Market Value Share Analysis, by Usage
13.6. Latin America Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel
13.7. Latin America Diabetes Injection Pens Market Attractiveness Analysis
13.8. Latin America Diabetes Injection Pens Market Trends
14. Rest of the World Diabetes Injection Pens Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Rest of the World Diabetes Injection Pens Market Value Share Analysis, by Country
14.4. Rest of the World Diabetes Injection Pens Market Value Share Analysis, by Product Type
14.5. Rest of the World Diabetes Injection Pens Market Value Share Analysis, by Usage
14.6. Rest of the World Diabetes Injection Pens Market Value Share Analysis, by Distribution Channel
14.7. Rest of the World Diabetes Injection Pens Market Attractiveness Analysis
14.8. Rest of the World Diabetes Injection Pens Market Trends
15. Competition Landscape
15.1. Diabetes Injection Pens Market Share Analysis By Company, 2018
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. Novo Nordisk A/S
15.3.1.1. Company Details
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Eli Lilly and Company
15.3.2.1. Company Details
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. AstraZeneca plc
15.3.3.1. Company Details
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Biocon Ltd.
15.3.4.1. Company Details
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Sanofi S.A.
15.3.5.1. Company Details
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Becton, Dickinson and Company
15.3.6.1. Company Details
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Owen Mumford Ltd.
15.3.7.1. Company Details
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. Jiangsu Delfu Co., Ltd.
15.3.8.1. Company Details
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Wockhardt Ltd.
15.3.9.1. Company Details
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.4. Other Prominent Companies in Diabetes Injection Pens Market
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers